Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentDelayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaquesAntigenic subversion: a novel mechanism of host immune evasion by Ebola virusProgress towards the treatment of Ebola haemorrhagic fever.The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection.A seroepidemiologic study of Reston ebolavirus in swine in the PhilippinesIdentification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry.Identification of a small-molecule entry inhibitor for filoviruses.Ebola virus pathogenesis: implications for vaccines and therapies.Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.Association of the caveola vesicular system with cellular entry by filovirusesCovalent modifications of the ebola virus glycoprotein.Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.The secret life of viral entry glycoproteins: moonlighting in immune evasion.Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.The multiple roles of sGP in Ebola pathogenesisEbola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization.Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy.Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates.Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure.Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparationsEbolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update.Filovirus entry: a novelty in the viral fusion world.Assembly of the Marburg virus envelope.Host cell factors in filovirus entry: novel players, new insightsEnhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
P2860
Q24597625-47FCC17A-90B0-4D83-A263-A84A2B0B5278Q24612811-99DDC6EF-8436-42FF-AAB5-8A0F11BC0C65Q27339643-729C8611-840C-4C5E-A762-66B6A2BE7221Q30230272-622F24F8-E869-4D69-B7D0-A09E49A55322Q30438367-EB3B9DDE-8015-44E9-88CC-0AEB2A449538Q30440969-66981315-7AF7-4D9A-987B-89F48D90D933Q31065625-A542A7DE-F8F1-4873-BDFA-4BDE1CDBA351Q33529421-BECAA1AF-BF16-4C0A-93C3-30C499283299Q33804801-A83DFE3F-35D4-48C5-8BD7-AB82624BEA2FQ33967985-D5725135-2ECF-4E59-B44E-EEF686EEBA81Q34059380-8561C9F4-2C5F-44DD-8D7A-AE2BEB62BA19Q34170237-D114AFE2-FDE0-47D3-9C3F-491CFFC62165Q34257290-049137AB-19C9-4FEF-A88A-A3235C51651DQ34317031-8B3B9712-F2C5-4326-ACBF-DB23EF6DDE66Q34326549-303C76B5-FDFE-4658-BD4A-56603076F91EQ34338277-8E252CC4-0E1D-4F52-83D4-66869AD4D057Q34354004-ABF8059E-C92B-4599-9D01-39BF5C6A9250Q34371001-7AA7C7FE-7024-4484-A801-3A4E6555B0C5Q34414075-9104C0C1-EFC5-4728-8BD6-EF3E671ED467Q34464533-968CFB93-FDAD-446D-8894-A805E3752520Q34500139-4EBC75BF-A4BC-4277-8EF3-3AF450665A5BQ34579231-74C694A3-03D6-42C1-8449-B0EF4FC103E1Q34733547-3FA72A10-10C0-4D12-8666-5FE3EEDEEEC1Q34761889-5DBB15AB-9F25-4E87-8EFF-E5975FF270A7Q34869463-2CD14CDB-7CB5-4C53-8F7F-F8945B82C359Q34969474-CA4D4B99-CDEC-4335-80AD-418EAD251149Q35034283-B503C782-A07F-48DB-BD50-DADE6C1B195CQ35107644-7B4B2BF4-3287-453C-B745-BF01E8F2EAF9Q35193047-4845145A-1842-40DC-9269-379C9E7F393CQ35784923-FAA78E0A-1017-4958-947C-93E7179D9AD3Q36370336-C0EC3F86-4BD3-47A1-83D0-68B5BFF63D89Q37007013-1D60D101-B445-4792-9EC4-4936312DB6CCQ37232054-58B5381A-02A2-4487-85C9-4E0CC7A6E66DQ37333887-4CB33B0C-FDAD-4A86-93A7-B9C0914754DAQ37866816-C9712286-EF13-410B-B750-5D0E18CB4C54Q37999360-61AFF66C-5EC9-4B96-98F8-51CFE18EF117Q38062931-A0B3B8BF-809A-4452-A4FD-513CCDF69535Q38076136-0BB0E68C-0860-4FDA-BD65-0FD4A80CDC09Q38785688-D22CB886-801E-47EA-B25E-64B097E6C54BQ38823675-C954EF68-D1E3-45A4-956B-D80609F1AAA6
P2860
Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Ebola virus glycoprotein: prot ...... ion of neutralizing antibodies
@en
Ebola virus glycoprotein: prot ...... on of neutralizing antibodies.
@nl
type
label
Ebola virus glycoprotein: prot ...... ion of neutralizing antibodies
@en
Ebola virus glycoprotein: prot ...... on of neutralizing antibodies.
@nl
prefLabel
Ebola virus glycoprotein: prot ...... ion of neutralizing antibodies
@en
Ebola virus glycoprotein: prot ...... on of neutralizing antibodies.
@nl
P2093
P2860
P921
P1433
P1476
Ebola virus glycoprotein: prot ...... ion of neutralizing antibodies
@en
P2093
P2860
P304
P356
10.1128/JVI.75.3.1576-1580.2001
P407
P577
2001-02-01T00:00:00Z